![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: HSPB1 |
Gene summary for HSPB1 |
![]() |
Gene information | Species | Human | Gene symbol | HSPB1 | Gene ID | 3315 |
Gene name | heat shock protein family B (small) member 1 | |
Gene Alias | CMT2F | |
Cytomap | 7q11.23 | |
Gene Type | protein-coding | GO ID | GO:0001525 | UniProtAcc | P04792 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
3315 | HSPB1 | GSM4909280 | Human | Breast | Precancer | 7.43e-04 | 4.23e-01 | 0.0305 |
3315 | HSPB1 | GSM4909281 | Human | Breast | IDC | 1.58e-04 | 1.35e-01 | 0.21 |
3315 | HSPB1 | GSM4909282 | Human | Breast | IDC | 3.02e-72 | 9.71e-01 | -0.0288 |
3315 | HSPB1 | GSM4909285 | Human | Breast | IDC | 1.58e-11 | 2.57e-01 | 0.21 |
3315 | HSPB1 | GSM4909286 | Human | Breast | IDC | 1.06e-15 | -7.60e-01 | 0.1081 |
3315 | HSPB1 | GSM4909288 | Human | Breast | IDC | 4.70e-02 | -4.58e-01 | 0.0988 |
3315 | HSPB1 | GSM4909290 | Human | Breast | IDC | 2.40e-08 | -6.55e-01 | 0.2096 |
3315 | HSPB1 | GSM4909291 | Human | Breast | IDC | 2.59e-77 | 1.30e+00 | 0.1753 |
3315 | HSPB1 | GSM4909293 | Human | Breast | IDC | 1.22e-04 | 2.69e-02 | 0.1581 |
3315 | HSPB1 | GSM4909296 | Human | Breast | IDC | 4.74e-57 | 9.63e-01 | 0.1524 |
3315 | HSPB1 | GSM4909297 | Human | Breast | IDC | 5.80e-12 | 4.31e-01 | 0.1517 |
3315 | HSPB1 | GSM4909298 | Human | Breast | IDC | 4.33e-10 | 3.05e-01 | 0.1551 |
3315 | HSPB1 | GSM4909301 | Human | Breast | IDC | 2.70e-110 | 1.16e+00 | 0.1577 |
3315 | HSPB1 | GSM4909302 | Human | Breast | IDC | 4.70e-20 | 6.65e-01 | 0.1545 |
3315 | HSPB1 | GSM4909304 | Human | Breast | IDC | 2.30e-59 | 8.19e-01 | 0.1636 |
3315 | HSPB1 | GSM4909306 | Human | Breast | IDC | 3.03e-49 | 7.89e-01 | 0.1564 |
3315 | HSPB1 | GSM4909307 | Human | Breast | IDC | 2.44e-42 | 7.99e-01 | 0.1569 |
3315 | HSPB1 | GSM4909308 | Human | Breast | IDC | 2.68e-71 | 1.01e+00 | 0.158 |
3315 | HSPB1 | GSM4909309 | Human | Breast | IDC | 2.02e-03 | 4.21e-01 | 0.0483 |
3315 | HSPB1 | GSM4909311 | Human | Breast | IDC | 1.10e-18 | 3.19e-01 | 0.1534 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:005134830 | Thyroid | HT | negative regulation of transferase activity | 45/1272 | 268/18723 | 1.49e-08 | 1.20e-06 | 45 |
GO:004206030 | Thyroid | HT | wound healing | 60/1272 | 422/18723 | 4.06e-08 | 2.69e-06 | 60 |
GO:200123430 | Thyroid | HT | negative regulation of apoptotic signaling pathway | 39/1272 | 224/18723 | 4.95e-08 | 3.15e-06 | 39 |
GO:003459929 | Thyroid | HT | cellular response to oxidative stress | 46/1272 | 288/18723 | 4.97e-08 | 3.15e-06 | 46 |
GO:006107726 | Thyroid | HT | chaperone-mediated protein folding | 19/1272 | 67/18723 | 5.92e-08 | 3.62e-06 | 19 |
GO:003410928 | Thyroid | HT | homotypic cell-cell adhesion | 22/1272 | 90/18723 | 1.03e-07 | 5.99e-06 | 22 |
GO:000181919 | Thyroid | HT | positive regulation of cytokine production | 61/1272 | 467/18723 | 6.46e-07 | 2.68e-05 | 61 |
GO:00321039 | Thyroid | HT | positive regulation of response to external stimulus | 55/1272 | 427/18723 | 3.50e-06 | 1.16e-04 | 55 |
GO:190040724 | Thyroid | HT | regulation of cellular response to oxidative stress | 19/1272 | 89/18723 | 6.62e-06 | 1.95e-04 | 19 |
GO:000646924 | Thyroid | HT | negative regulation of protein kinase activity | 33/1272 | 212/18723 | 6.62e-06 | 1.95e-04 | 33 |
GO:190320124 | Thyroid | HT | regulation of oxidative stress-induced cell death | 17/1272 | 74/18723 | 7.10e-06 | 2.04e-04 | 17 |
GO:200124328 | Thyroid | HT | negative regulation of intrinsic apoptotic signaling pathway | 20/1272 | 98/18723 | 7.87e-06 | 2.23e-04 | 20 |
GO:003367324 | Thyroid | HT | negative regulation of kinase activity | 35/1272 | 237/18723 | 1.16e-05 | 3.05e-04 | 35 |
GO:190217525 | Thyroid | HT | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway | 10/1272 | 29/18723 | 1.23e-05 | 3.21e-04 | 10 |
GO:000193327 | Thyroid | HT | negative regulation of protein phosphorylation | 45/1272 | 342/18723 | 1.54e-05 | 3.80e-04 | 45 |
GO:004232627 | Thyroid | HT | negative regulation of phosphorylation | 49/1272 | 385/18723 | 1.62e-05 | 3.95e-04 | 49 |
GO:004593629 | Thyroid | HT | negative regulation of phosphate metabolic process | 54/1272 | 441/18723 | 1.86e-05 | 4.39e-04 | 54 |
GO:006024917 | Thyroid | HT | anatomical structure homeostasis | 42/1272 | 314/18723 | 1.98e-05 | 4.60e-04 | 42 |
GO:001056329 | Thyroid | HT | negative regulation of phosphorus metabolic process | 54/1272 | 442/18723 | 1.99e-05 | 4.60e-04 | 54 |
GO:190288225 | Thyroid | HT | regulation of response to oxidative stress | 19/1272 | 98/18723 | 2.82e-05 | 6.13e-04 | 19 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa051465 | Cervix | CC | Amoebiasis | 29/1267 | 102/8465 | 3.31e-04 | 1.70e-03 | 1.01e-03 | 29 |
hsa040109 | Cervix | CC | MAPK signaling pathway | 62/1267 | 302/8465 | 4.89e-03 | 1.67e-02 | 9.86e-03 | 62 |
hsa0514612 | Cervix | CC | Amoebiasis | 29/1267 | 102/8465 | 3.31e-04 | 1.70e-03 | 1.01e-03 | 29 |
hsa0401012 | Cervix | CC | MAPK signaling pathway | 62/1267 | 302/8465 | 4.89e-03 | 1.67e-02 | 9.86e-03 | 62 |
hsa040102 | Colorectum | CRC | MAPK signaling pathway | 56/1091 | 302/8465 | 2.76e-03 | 1.77e-02 | 1.20e-02 | 56 |
hsa040103 | Colorectum | CRC | MAPK signaling pathway | 56/1091 | 302/8465 | 2.76e-03 | 1.77e-02 | 1.20e-02 | 56 |
hsa051466 | Endometrium | AEH | Amoebiasis | 29/1197 | 102/8465 | 1.22e-04 | 1.10e-03 | 8.06e-04 | 29 |
hsa0514613 | Endometrium | AEH | Amoebiasis | 29/1197 | 102/8465 | 1.22e-04 | 1.10e-03 | 8.06e-04 | 29 |
hsa0514622 | Endometrium | EEC | Amoebiasis | 28/1237 | 102/8465 | 5.23e-04 | 3.83e-03 | 2.85e-03 | 28 |
hsa0514632 | Endometrium | EEC | Amoebiasis | 28/1237 | 102/8465 | 5.23e-04 | 3.83e-03 | 2.85e-03 | 28 |
hsa040108 | Lung | IAC | MAPK signaling pathway | 62/1053 | 302/8465 | 3.54e-05 | 6.38e-04 | 4.24e-04 | 62 |
hsa051464 | Lung | IAC | Amoebiasis | 23/1053 | 102/8465 | 2.99e-03 | 1.53e-02 | 1.02e-02 | 23 |
hsa0401011 | Lung | IAC | MAPK signaling pathway | 62/1053 | 302/8465 | 3.54e-05 | 6.38e-04 | 4.24e-04 | 62 |
hsa0514611 | Lung | IAC | Amoebiasis | 23/1053 | 102/8465 | 2.99e-03 | 1.53e-02 | 1.02e-02 | 23 |
hsa0401021 | Lung | AIS | MAPK signaling pathway | 57/961 | 302/8465 | 6.41e-05 | 9.43e-04 | 6.03e-04 | 57 |
hsa0514621 | Lung | AIS | Amoebiasis | 20/961 | 102/8465 | 9.86e-03 | 4.20e-02 | 2.69e-02 | 20 |
hsa0401031 | Lung | AIS | MAPK signaling pathway | 57/961 | 302/8465 | 6.41e-05 | 9.43e-04 | 6.03e-04 | 57 |
hsa0514631 | Lung | AIS | Amoebiasis | 20/961 | 102/8465 | 9.86e-03 | 4.20e-02 | 2.69e-02 | 20 |
hsa040104 | Lung | AAH | MAPK signaling pathway | 27/348 | 302/8465 | 1.13e-04 | 6.32e-03 | 5.08e-03 | 27 |
hsa040105 | Lung | AAH | MAPK signaling pathway | 27/348 | 302/8465 | 1.13e-04 | 6.32e-03 | 5.08e-03 | 27 |
Page: 1 2 3 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
HSPB1 | SNV | Missense_Mutation | novel | c.503N>A | p.Pro168His | p.P168H | P04792 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-A7-A0DB-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | arimidex | SD |
HSPB1 | SNV | Missense_Mutation | novel | c.513G>T | p.Lys171Asn | p.K171N | P04792 | protein_coding | tolerated(0.06) | benign(0.223) | TCGA-E6-A2P9-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
HSPB1 | SNV | Missense_Mutation | novel | c.574N>T | p.Gly192Trp | p.G192W | P04792 | protein_coding | deleterious(0) | probably_damaging(0.995) | TCGA-55-1595-01 | Lung | lung adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
HSPB1 | SNV | Missense_Mutation | novel | c.413N>G | p.Phe138Cys | p.F138C | P04792 | protein_coding | deleterious(0) | probably_damaging(0.986) | TCGA-NC-A5HR-01 | Lung | lung squamous cell carcinoma | Female | >=65 | I/II | Chemotherapy | carboplatin | CR |
HSPB1 | insertion | Frame_Shift_Ins | rs747325717 | c.432_433insC | p.Gly147ArgfsTer14 | p.G147Rfs*14 | P04792 | protein_coding | TCGA-CD-A4MG-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
3315 | HSPB1 | DRUGGABLE GENOME | DIFFERENTIATION AGENTS | 8065161 | ||
3315 | HSPB1 | DRUGGABLE GENOME | TRIAMTERENE | TRIAMTERENE | ||
3315 | HSPB1 | DRUGGABLE GENOME | UREA | UREA | 9094264 | |
3315 | HSPB1 | DRUGGABLE GENOME | QUERCETIN | QUERCETIN | 19296652 | |
3315 | HSPB1 | DRUGGABLE GENOME | TYROSINE KINASE INHIBITOR | 8875961 | ||
3315 | HSPB1 | DRUGGABLE GENOME | inhibitor | OGX-427 | APATORSEN | |
3315 | HSPB1 | DRUGGABLE GENOME | PHENANTHROLINE | PHENANTHROLINE | ||
3315 | HSPB1 | DRUGGABLE GENOME | DIFFERENTIATION INDUCER | 7500647 | ||
3315 | HSPB1 | DRUGGABLE GENOME | DICARBONODITHIOIMIDIC DIAMIDE | DICARBONODITHIOIMIDIC DIAMIDE | ||
3315 | HSPB1 | DRUGGABLE GENOME | BENZENETHIOL | BENZENETHIOL |
Page: 1 2 3 4 |